Premium
LAI antipsychotics delay hospitalization in patients with early‐phase schizophrenia
Publication year - 2020
Publication title -
the brown university psychopharmacology update
Language(s) - English
Resource type - Journals
eISSN - 1556-7532
pISSN - 1068-5308
DOI - 10.1002/pu.30639
Subject(s) - aripiprazole , schizophrenia (object oriented programming) , psychiatry , medicine , psychopharmacology , pediatrics , psychology
Use of long‐acting aripiprazole increased time to first hospitalization compared with usual care in young‐adult patients with early‐phase schizophrenia, a randomized trial has found. The findings suggest that long‐acting injectable (LAI) antipsychotics should receive more consideration as a treatment option in early stages of schizophrenia, the researchers concluded. Study results were published online July 15, 2020, in JAMA Psychiatry .
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom